Deduced probable HLA-C*07:359-associated human leukocyte antigen haplotypes found by case analysis of Taiwanese unrelated bone marrow hematopoietic stem cell donors  by Yang, Kuo-Liang
lable at ScienceDirect
Tzu Chi Medical Journal 28 (2016) 59e62Contents lists avaiTzu Chi Medical Journal
journal homepage: www.tzuchimedjnl .comOriginal ArticleDeduced probable HLA-C*07:359-associated human leukocyte antigen
haplotypes found by case analysis of Taiwanese unrelated bone
marrow hematopoietic stem cell donors
Kuo-Liang Yang a, b, *
a Laboratory of Immunogenetics, Tzu Chi Cord Blood Bank and Buddhist Tzu Chi Marrow Donor Registry, Buddhist Tzu Chi Stem Cells Centre, Hualien Tzu Chi
Hospital, Hualien, Taiwan
b Department of Laboratory Medicine, Buddhist Tzu Chi University, Hualien, Taiwana r t i c l e i n f o
Article history:
Received 24 February 2016
Received in revised form
14 March 2016
Accepted 18 March 2016
Available online 27 May 2016
Keywords:
Haplotype
Hematopoietic stem cell
Human leukocyte antigen
Sequence-based typing
TransplantationConﬂict of interest: none.
* Corresponding author. Buddhist Tzu Chi Stem C
Hospital, 707, Section 3, Chung-Yang Road, Hu
38561825x3373; fax: þ886 38567851.
E-mail address: edward@tzuchi.com.tw.
http://dx.doi.org/10.1016/j.tcmj.2016.04.004
1016-3190/Copyright © 2016, Buddhist Compassion Re
(http://creativecommons.org/licenses/by-nc-nd/4.0/).a b s t r a c t
Objectives: HLA-C*07:359 is a low-incidence allele in the human leukocyte antigen (HLA)-C locus. The
objective of this study is to report the ethnicity and haplotypes of HLA-C*07:359 that were found during
an analysis of Taiwanese unrelated bone marrow hematopoietic stem cell donors.
Materials and methods: A sequence-based typing method was employed to conﬁrm low-incidence al-
leles. Polymerase chain reaction was performed to amplify exon 2 and exon 3 of the HLA-A, HLA-B, and
HLA-C loci, as well as exon 2 of the HLA-DRB1 locus, using group-speciﬁc primer sets. The amplicons
were sequenced in both directions using BigDye Terminator Cycle Sequencing Ready Reaction kits, ac-
cording to the manufacturer's protocols. The potential unrelated bone marrow stem cell donors inves-
tigated here are individuals with Taiwanese ethnicity who are participating in the Tzu Chi Bone Marrow
Donor Registry.
Results: The DNA sequence of C*07:359 is identical to that of C*07:02:01:01 in exons 2, 3, and 4 except at
residue 862, where the G of C*07:02:01:01 is substituted by the A of C*07:359. The nucleotide exchange
leads to an amino acid replacement at codon 264, where the glutamic acid of C*07:02:01:01 is replaced
by the lysine of C*07:359. We deduced a probable HLA-B and HLA-C haplotype that is associated with
C*07:359 in Taiwanese, namely B*39-C*07:359.
Conclusion: Information on the ethnicity of the C*07:359 allele and its deduced probable HLA haplotypes
that are associated with the low-incidence C*07:359 allele reported here are of value to HLA testing
laboratories for reference purposes. In addition, they can be used by stem cell transplantation donor
search coordinators to determine a strategy for ﬁnding compatible donors using unrelated bone marrow
donor registries when patients carry this uncommon HLA allele.
Copyright © 2016, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).1. Introduction
New human leukocyte antigen (HLA) alleles continue to be
revealed, and the recognition of HLA low-incidence alleles has
enriched our understanding of the complexity of the HLA system.
The major histocompatibility complex (MHC) in humans consists of
several gene loci that are located on the short arm of chromosome 6ells Centre, Hualien Tzu Chi
alien, Taiwan. Tel.: þ886
lief Tzu Chi Foundation. Publishedat 6p21.3. These loci are classiﬁed intoMHC class I, II, and III regions.
The genes encoding the HLA alleles are located in MHC class I and II
regions. These HLA genes are characterized by their extreme allelic
polymorphism, as well as their variation and diversity across
different ethnic groups and racial populations. HLA molecules have
been deﬁnitively deﬁned as transplant antigens and have a strong
relevance to tissue transplantation. The presence of molecular
similarity between donors and recipients is considered to be a
predictive factor regarding graft survival and graft versus host
disease. It is imperative to precisely characterize any unknown and
low-incidence alleles encountered during routine HLA typing pro-
cedures. To facilitate successful and comprehensive unrelated bone
marrow hematopoietic stem cell donor searches for patients inby Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
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Fig. 1. (A) The DNA sequence of C*07:359 is identical to that of C*07:02:01:01 in exons 2, 3, and 4 except at residue 862, where the G of C*07:02:01:01 is substituted by the A in
C*07:359 (shaded; codon 264; underlined). Exons 2 and 3 are separated by pipes (j) between nucleotides 343 and 344, and exons 3 and 4 are separated by pipes (j) between
nucleotides 619 and 620. (B) Nucleotide exchange leads to an amino acid replacement at codon 264 where the E (glutamic acid) of C*07:02:01:01 is replaced by the K (lysine) in
C*07:359 (shaded). The dashes indicate nucleotide or amino acid identity with C*07:02:01:01.
K.-L. Yang / Tzu Chi Medical Journal 28 (2016) 59e6260need of hematopoietic stem cell transplantation, persistent efforts
are needed to resolve unidentiﬁed, ambiguous, or low-incidence
alleles in order to offer better HLA matching and improved donor
selection.
The DNA sequence of C*07:359 was ﬁrst submitted to IMGT/HLA
database in January 2014 without any indication as to its ethnicity
and haplotype [1]. A second C*07:359 submission to the IMGT/HLA
database was submitted in June 2014 [1] by Tzu Chi Immunoge-
netics Laboratory, and the donor in this case was a Taiwanese in-
dividual. There was no report at that time of a haplotype associated
with C*07:359 because of a lack of blood samples from the family of
the donor with this allele.2. Materials and methods
Potential unrelated bone marrow stem cell donors are in-
dividuals with Taiwanese ethnicity who participate in the Tzu Chi
Bone Marrow Donor Registry and who have given informed con-
sent. Peripheral whole blood samples from eight unrelated bone
marrow hematopoietic stem cell donors with Taiwanese ethnicity
were collected in acid citrate dextrose anticoagulant. Formal writ-
ten consents were signed by the donors before blood collection. The
acid citrate dextrose whole blood samples were stored at 80C
until use. Genomic DNA was extracted using the QIAamp DNA
Blood Mini kits according to the manufacturer's instructions
Table 1
Deduced probable HLA-A, HLA-B, and HLA-C haplotypes associated with C*07:359 in Taiwanese.
Donor ID HLA-A* HLA-B* HLA-C* HLA-DRB1* Ethnicity Deduced probable C*07:359-associated
HLA haplotype
313413 11 24 39 40 03:04 07:359 04 15 Taiwanese B*39-C*07:359
331307 11 02 39 46 01:08 07:359 12 16 Taiwanese B*39-C*07:359
357339 02:01 24:02 39:01 40:01 07:02 07:359 04:04 04:05 Taiwanese B*39-C*07:359
368267 11:02 24:02 39:01 40:01 07:02 07:359 04:04 04:05 Taiwanese B*39-C*07:359
371042 24:02 d 39:01 40:01 03:04 07:359 04:04 04:05 Taiwanese B*39-C*07:359
R39387 24:02 34:01 39:01 40:01 04:82 07:359 04:04 04:05 Taiwanese B*39-C*07:359
AB3586 24:02 33:03 15:25 39:01 04:03 07:359 04:04 12:02 Taiwanese B*39-C*07:359
295076 24 d 39 56 01:02 07:359 04 15 Taiwanese B*39-C*07:359
ABAL772993 (1) 02 03:01 07:02 08:01 07:02 07:359 03:01 04:05 Unknown ?
HLA ¼ human leukocyte antigen.
K.-L. Yang / Tzu Chi Medical Journal 28 (2016) 59e62 61(Qiagen, Hilden, Germany). The DNA samples were subjected to
HLA genotyping for the HLA-A, HLA-B, HLA-C, and HLA-DRB1 loci
using commercial polymerase chain reaction-sequencing-based
typing kits (Secore A/B/C/DRB1 Locus Sequencing kits; Life Tech-
nologies, Brown Deer, WI, USA). High-resolution allelic sequencing
was performed as previously described [2e7]. The following two
sets of primer sequences were used: (1) B-CG: M13-BIN1-CGG
(sense): TGTAAAACGACGGCCAGTCGGGGGCGCAGGACCCGG; P30
exon 5B (antisense): GCTCCGATGACCACAACTGCT and (2) B-TA:
M13-BIN1-TGA (sense): TGTAAAACGACGGCCAGTGGCGGGGGCG-
CAGGACCTGA; P30 exon 5B (antisense): GCTCCGATGACCA-
CAACTGCT. The amplicons were sequenced in both directions using
a BigDye Terminator Cycle Sequencing Ready Reaction kit (Applied
Biosystems, Foster City, CA, USA).
Determination of the HLA allele-associated probable haplotype,
which was carried out in this study, involved looking at the
commonly shared HLA typing of the donors carrying C*07:359.
Where applicable, haplotype deduction based on HLA allelic ho-
mozygosity was carried out as described previously [8,9]. For
example, if a donor is typed for HLA-A, HLA-B, and HLA-DRB1 as
having A*33:03, -, B*58:01, -, DRB1*03:01, -, it is possible to deduce
the putative haplotypes of the donor derived from the biological
parents as HLA-A*33:03-B*58:01-DRB1*03:01 and A*33:03-B*58:01-
DRB1*03:01. On the same token, if the typing of a donor is A*02:01,
A*02:07, B*46:01, -, DRB1*09:01, -, the putative haplotypes of the
donor are A*02:01-B*46:01-DRB1*09:01 and A*02:07-B*46:01-
DRB1*09:01 [9].
3. Results
In this study, the DNA and protein sequences and the Taiwanese
ethnicity of the C*07:359 allele were conﬁrmed. The DNA sequence
of C*07:359 is identical to that of C*07:02:01:01 (frequency 20%) in
exons 2, 3, and 4 except at residue 862, where the G of
C*07:02:01:01 is substituted by the A in C*07:359 (Fig. 1A). The
nucleotide exchange leads to an amino acid replacement at codon
264 where the E (glutamic acid) of C*07:02:01:01 is replaced by the
K (lysine) in C*07:359 (Fig. 1B). From the eight Taiwanese unrelated
potential bone marrow donors studied here (Table 1), it is apparent
that C*07:359 is closely linked with B*39 in the HLA-B locus, as all
the eight donors with C*07:359 were found to bear the B*39 allele.
However, when the HLA-A alleles of the donors are taken into
consideration, two probable HLA-A, HLA-B, and HLA-C haplotypes
may be determined in Taiwanese donors, namely A*11-B*39-
C*07:359 and A*24:02-B*39-C*07:359. This indicates that B*39-
C*07:359 haplotype is not strictly restricted to a particular allele
in the HLA-A locus. This variable linkage phenomenon is also
observed in the case of C*07:359-carrying cells (ABAL 772993)
submitted to the IMGT/HLA database (1). The C*07:359 allele of the
ABAL 772993 cells is linked neither to B*39 in the HLA-B locus norto A*11 or A*24 in the HLA-A locus, which was the case with the
Taiwanese studied. Therefore, the haplotype HLA-B*39-C*359 is
possibly strictly restricted to individuals of Taiwanese ethnicity.
4. Discussion
In this study, the Taiwanese ethnicity of C*07:359 and the DNA
and protein sequences of C*07:359 allele were conﬁrmed. Further,
C*07:359 was found to be linked closely to B*39. However, the
B*39-C*07:359 haplotype is not strictly restricted to associate with
a particular HLA-A allele. Therefore, two probable HLA-C*07:359-
associated HLA-A, HLA-B, and HLA-C haplotypes that are present
in the Taiwanese population were identiﬁed. Furthermore, in the
case of the C*07:359-carrying cells (ABAL 772993) that were sub-
mitted to the IMGT/HLA database (1), this is linked neither to B*39
in the HLA-B locus nor to A*11 or A*24 in the HLA-A locus. Further
investigation on ABAL 772993 is still pending and its associated
HLA haplotype remains undetermined.
It is worth mentioning that the most direct and classic method
to determine HLA haplotypes is through a family study if samples
from appropriate key family members are available. Alternatively, a
population study may be employed if a signiﬁcant number of un-
related donors are available [3]. However, the haplotypes deduced
via population-based investigation are considered to be likely or
most probable rather than certain. In this study, because of the lack
of availability of necessary test material from the family of donors
with C*07:359, determination of the haplotypes was carried out by
examining the HLA alleles carried in common by unrelated donors
bearing the same allele of interest. By the same token, if determi-
nation of plausible HLA haplotypes involves rare or low-frequency
HLA alleles, the alleles shared in common by unrelated individuals
can be employed to deduce associated probable haplotypes
[4e7,10e13].
The frequency of C*07:359 in Taiwanese is about 0.03%, ac-
cording to our HLA typing practice. Furthermore, up to the present,
the Allele Frequency Net Database (http://www.allelefrequencies.
net/hla6006a.asp?hla_locus_type¼Classical#) has yet to show the
existence of the C*07:359 allele in the world's population outside of
Taiwan.
The signiﬁcance of determining the ethnicity of individuals with
C*07:359 and its HLA-linked haplotypes is that the information
may be employed in anthropological investigation of races. In
addition, it also helps search coordinators, using unrelated bone
marrow donor registries, in identifying appropriate unrelated bone
marrow hematopoietic stem cell donors for their patients.
The number of knownHLA alleles is increasing exponentially due
to recent developments in DNA-based molecular typing technology.
The outstanding HLA diversity in ethnic groups is unique and
important. Facilitation of the identiﬁcation of an appropriate HLA-
matched unrelated bone marrow stem cell donor, which will
K.-L. Yang / Tzu Chi Medical Journal 28 (2016) 59e6262allow successful stem cell transplantations, relies on the accuracy of
HLA typing and the spirit and strength to resolve the various un-
known, ambiguous, and low-incidence genes present in the HLA
system. Additionally, determination of haplotype is essential for the
matching of unrelated stem cell transplantation between the donor
and the recipient, since matching at the haplotype level has a better
likelihood of achieving a match at other loci within the HLA region
thanwhen donors are merely matched at the individual allelic level.
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